Defence Therapeutics Inc.
DTCFF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$505 | -$851 | -$952 | -$805 |
| Dep. & Amort. | $12 | $14 | $18 | $18 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $421 | $160 |
| Change in WC | -$159 | $54 | -$1,411 | -$146 |
| Other Non-Cash | $135 | $178 | -$72 | $105 |
| Operating Cash Flow | -$517 | -$605 | -$1,996 | -$668 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$15 | $0 | $0 | $0 |
| Net Acquisitions | $0 | -$11 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $19 |
| Investing Cash Flow | -$15 | -$11 | $0 | $19 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $1,436 | $0 | -$23 | -$129 |
| Stock Issued | $0 | -$5 | $4,215 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$126 | -$2 | -$247 | $779 |
| Financing Cash Flow | $1,310 | -$7 | $3,945 | $649 |
| Forex Effect | -$16 | $83 | $0 | $0 |
| Net Chg. in Cash | $761 | -$540 | $1,949 | -$1 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $905 | $1,445 | $131 | $131 |
| End Cash | $1,666 | $905 | $2,080 | $131 |
| Free Cash Flow | -$533 | $0 | -$1,996 | -$668 |